World Journal of Vaccines

Vol.5 No.2(2015), Paper ID 55964, 23 pages

DOI:10.4236/wjv.2015.52013

 

HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy

 

Maxwell Omabe, Shahid Ahmed, Amer Sami, Yufeng Xie, Min Tao, Jim Xiang

 

Cancer Research Cluster, Saskatchewan Cancer Agency, Saskatoon, Canada
Department of Oncology, University of Saskatchewan, Saskatoon, Canada
Department of Oncology, University of Saskatchewan, Saskatoon, Canada
Department of Oncology, The first Affiliated Hospital, Soo-Chow University, Suzhou, China
Department of Oncology, The first Affiliated Hospital, Soo-Chow University, Suzhou, China
Cancer Research Cluster, Saskatchewan Cancer Agency, Saskatoon, Canada

 

Copyright © 2015 Maxwell Omabe, Shahid Ahmed, Amer Sami, Yufeng Xie, Min Tao, Jim Xiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Omabe, M. , Ahmed, S. , Sami, A. , Xie, Y. , Tao, M. and Xiang, J. (2015) HER2-Specific Vaccines for HER2-Positive Breast Cancer Immunotherapy. World Journal of Vaccines, 5, 106-128. doi: 10.4236/wjv.2015.52013.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.